Cellular rules underlying psychedelic control of prefrontal pyramidal neurons
Contrary to the prevailing view that psychedelics increase pyramidal cell excitability via 5‑HT2A receptors, this study shows multiple classes of psychedelics dose‑dependently suppress intrinsic excitability of prefrontal pyramidal neurons by enhancing M‑current potassium channels independently of 5‑HT2A activation, with extracellular application producing larger effects than intracellular. Machine‑learning modelling indicates M‑current activation interacts with other mechanisms to markedly reduce excitability and shorten working‑memory timespan, implying modulation of ubiquitous ion channels may drive homeostatic changes that contribute to broad therapeutic benefits.
Abstract
Classical psychedelic drugs are thought to increase excitability of pyramidal cells in prefrontal cortex via activation of serotonin 2 A receptors (5-HT2 A Rs). Here, we instead find that multiple classes of psychedelics dose-dependently suppress intrinsic excitability of pyramidal neurons, and that extracellular delivery of psychedelics decreases excitability significantly more than intracellular delivery. A previously unknown mechanism underlies this psychedelic drug action: enhancement of ubiquitously expressed potassium “M-current” channels that is independent of 5-HT2R activation. Using machine-learning-based data assimilation models, we show that M-current activation interacts with previously described mechanisms to dramatically reduce intrinsic excitability and shorten working memory timespan. Thus, psychedelic drugs suppress intrinsic excitability by modulating ion channels that are expressed throughout the brain, potentially triggering homeostatic adjustments that can contribute to widespread therapeutic benefits.
Research Summary of 'Cellular rules underlying psychedelic control of prefrontal pyramidal neurons'
Introduction
Ekins and colleagues frame the study against the prevailing model that classical serotonergic psychedelics acutely increase excitability of prefrontal cortex (PFC) pyramidal neurons via activation of serotonin 2A receptors (5-HT2ARs), a process thought to contribute to lasting synaptic remodelling. They note that neuronal excitability has two main components — intrinsic membrane properties and synaptic input — and that prior work attributing increased intrinsic excitability to resting membrane potential (RMP) depolarisation and reduced afterhyperpolarisation does not capture all reported cellular effects of these drugs, including increased inactivation of transient sodium channels. The authors therefore identify a gap: it remains unclear whether serotonergic psychedelics universally enhance intrinsic excitability of PFC pyramidal cells (PCs) through extracellular 5-HT2AR activation. This study tests that hypothesis using an integrative approach combining whole‑cell electrophysiology, morphology, pharmacology, machine‑learning data assimilation, and computational modelling. The investigators aim to determine how different serotonergic psychedelics affect intrinsic and synaptic excitability of layer 5 PFC PCs, whether intracellular versus extracellular drug delivery matters, which ion channel mechanisms underlie any changes, and how those mechanisms might influence cell‑level correlates of working memory.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Author
- APA Citation
Ekins, T. G., Brooks, I., Kailasa, S., Rybicki-Kler, C., Jedrasiak-Cape, I., Donoho, E., Mashour, G. A., Rech, J., & Ahmed, O. J. (2023). Cellular rules underlying psychedelic control of prefrontal pyramidal neurons. https://doi.org/10.1101/2023.10.20.563334
References (27)
Papers cited by this study that are also in Blossom
Leary, T., Litwin, G. H., Metzner, R. · Journal of Nervous and Mental Disease (1977)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Studerus, E., Kometer, M., Hasler, F. et al. · Journal of Psychopharmacology (2010)
Wittmann, M., Carter, O., Hasler, F. et al. · Journal of Psychopharmacology (2007)
Barrett, F. S., Carbonaro, T. M., Hurwitz, E. et al. · Psychopharmacology (2018)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Doss, M. K., Považan, M., Rosenberg, M. D. et al. · Translational Psychiatry (2021)
Davis, A. K., Barrett, F. S., May, D. G. et al. · JAMA Psychiatry (2021)
Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)
Davis, A. K., Streeter Barrett, F., Cosimano, M. P. et al. · Journal of Psychopharmacology (2022)
Show all 27 referencesShow fewer
Goodwin, G. M., Aaronson, S. T., Alvarez, O. et al. · New England Journal of Medicine (2022)
Vollenweider, F. X., Kometer, M. · Nature Reviews Neuroscience (2010)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Doss, M. K., Madden, M. B., Gaddis, A. et al. · Brain (2021)
Kwan, A. C., Olson, D. E., Preller, K. H. et al. · Nature Medicine (2022)
Ly, C., Greb, A. C., Cameron, L. P. et al. · Cell Reports (2018)
Shao, L-X,, Liao, C., Gregg, I. et al. · Neuron (2021)
Vargas, M. V., Dunlap, L. E., Dong, C. et al. · Science (2023)
De La, M., Revenga, F., Zhu, B. et al. · Cell Reports (2021)
Cameron, L. P., Tombari, R. J., Lu, J. et al. · Nature (2020)
Kim, K., Che, T., Panova, O. et al. · Cell (2020)
Klein, A. K., Chatha, M., Laskowski, L. J. et al. · ACS Pharmacology and Translational Science (2020)
Halberstadt, A. L., Chatha, M., Klein, A. K. et al. · Neuropharmacology (2020)
Chiu, Y. T., Deutch, A. Y., Wang, W. et al. · Biorxiv (2023)
Domenico, C., Haggerty, D., Mou, X. et al. · Cell Reports (2021)
Nardou, R., Sawyer, E., Song, Y. J. et al. · Nature (2023)
Yehuda, R., Lepow, L., Morishita, H. · Frontiers in Neuroscience (2021)
Cited By (3)
Papers in Blossom that reference this study
Safron, A., Juliani, A., Reggente, N. et al. · Neuroscience of Consciousness (2025)
Anderson, T. L., Keady, J. V., Songrady, J. et al. · Progress in Neurobiology (2024)
De Filippo, R., Schmitz, D. · Neuroscience and Biobehavioral Reviews (2024)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.